After obtaining a Master’s degree in Life Sciences from the “École Pratique des Hautes Études” (Paris Sciences and Letters University) in 2022, Marina Villaverde has just started a PhD thesis. Through the collaboration between the Institute for Regenerative Medicine and Biotherapies and HCS Pharma, this PhD work will focus on the development of a new osteoarthritic model in vitro with the 3D BIOMIMESYS® technology in order to identify new therapies for this common and so far uncured disease.


Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.